19
Dr. Lluís Rovira Director of CERCA [email protected]

Dr. Lluís Rovira Director of CERCA [email protected]/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 6: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

0 2000 4000 6000 8000 10000

Biomedicine

Engineering

Life Sciences & Agrofood

Sciences

Social Sciences & Humanities

CERCA Staff (Researchers & others)

Women Men

Page 9: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

CERCAセンターは、EU H2020フレームワークプログラムの融資とプロジェクトに関して、重要な役割を持つEUの主要科学10機関の1つになっています。

Page 10: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

€ 264.891.279

€ 266.530.969

€ 291.391.455

€ 322.337.459

€ 342.056.387

€ 363.931.222

€ 400.218.385

€ 504.658.331

€ 532.152.026

€ 621.304.593

€ 869.793.938

KOBENHAVNS UNIVERSITET

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

UNIVERSITY COLLEGE LONDON

CERCA

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

Germany

Germany

France

France

UK

UK

UK

Catalonia

Switzerland

Switzerland

Denmark

Source: European Commission (Decembre 2019)

Page 12: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

CERCAGÍNJOL Patents Fund

Page 15: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

Start up CERCA

FOREST BIOENGINEERING SOLUTIONS

OWL GENOMICS

VOLTA NETWORKS

TRANSMURAL BIOTECH

WATCHITY

ALERIA BIODEVICES SL

GLYCARDIAL DIAGNOSTICS SL

MEDIGENIUM SL

LINKCARE

IMMUNOVATIVE DEVELOPMENTS

ESTRIMTRACK

BIOMARKERS CLINICAL DIAGNOSIS & APPLICATIONS

AELIX THERAPEUTICS

TRANSPLANT BIOMEDICALINNOVEX THERAPEUTICS

FREEOXBLB SL

BIONURE

RADIANT LIGHT SL

REMAB

ADDMIT

MANRESANA DE MICOBACTERIOLOGIA SL TRACTIVUS

ANILING SL

GOODGUT SL

XENOPAT

VCN BIOSCIENCES

VIRTUAL BODYWORKS

NANOLIGENT

BLUMENTECH

LEDMOTIVEPHARMATOOLS DIGITAL INTERACTIVE SERVICES

CHEMOTARGETS

BIOSFER TESLAB

NANOTHERAPIX

IMIDOMICS

IDETAN

PEPTOMYC

MOSAIC BIOMEDICALS

SURGITRAINER

Page 16: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

Impacts from CERCA• CARLA: democratising autonomous driving with an open source Simulator. CVC

• Positive response of cardíac patients to a bioengineering implant designed to repair heart tissue. IBEC

• (Nano)capsules for a more aromàtic laundry. ICN2

• Full or near complete recovery of autoimmune encephalitis

• Yaws, from finding a treatment in a remote island to potential elimination worlwide

• Improving people’s well being in Health and work places with smart spectraly tunable lightingsystem

Page 18: Dr. Lluís Rovira Director of CERCA llrovirap@gencatphantomsfoundation.com/1AND2DM/2020/Presentations/Nano...LINKCARE IMMUNOVATIVE DEVELOPMENTS ESTRIMTRACK BIOMARKERS CLINICAL DIAGNOSIS

The Government approves thecreation of the CERCA Institution . April 13th 2010